Dublin, Aug. 31, 2022 (GLOBE NEWSWIRE) -- The "Monoclonal Antibodies (MAbS) Global Market Report 2022: By Source, By Application, By End-User" report has been added to ResearchAndMarkets.com's ...
Monoclonal antibodies (mAbs) have been a key therapeutic option for non-communicable diseases for decades, and a small number of mAbs have helped treat infectious diseases, including COVID-19. The ...
In their recent statements announcing price reductions, energy companies have pointed to their collaborations with Mabs to support people who are in difficulty paying their bills. New statistics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results